Literature DB >> 15089001

Evaluation of a consecutive group of transsexual individuals referred for vocal intervention in the west of Sweden.

Ewa Söderpalm1, AnnaKarin Larsson, Sven-Ake Almquist.   

Abstract

Male-to-female transsexual individuals frequently experience difficulties in increasing the fundamental frequency so that they can pass as members of the preferred gender. Female-to-male individuals may also meet with vocal problems although hormone treatment lowers fundamental frequency. The purpose of this study was to explore the transsexual individuals who, as part of their reassignment process, were referred to the voice clinic at the Sahlgrenska University Hospital in Göteborg, Sweden, between 1991 and 2002. The group comprised 22 male-to-female and 3 female-to-male transsexuals. Video recorded laryngeal examinations revealed basically normal conditions. More than half the patients showed supraglottal constriction on phonating at both habitual and preferred levels. A comparison between acoustic analyses before therapy and at follow-up visits showed increased fundamental frequencies for male-to-female individuals (p = < 0.01). Vocal fatigue was reduced. Degree of satisfaction with the post-therapy voice was not related to number of therapy sessions.

Entities:  

Mesh:

Year:  2004        PMID: 15089001     DOI: 10.1080/14015430310021618

Source DB:  PubMed          Journal:  Logoped Phoniatr Vocol        ISSN: 1401-5439            Impact factor:   1.487


  2 in total

1.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

2.  Combined type IIIB with bilateral type I thyroplasty for pitch lowering with maintenance of vocal fold tension.

Authors:  Matthew R Hoffman; Erin E Devine; Marc Remacle; Charles N Ford; Elizabeth Wadium; Jack J Jiang
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-16       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.